Melissa Beiner, M.D., SCA Clinical Development Lead at Biohaven, commented, Our NDA filing is the culmination of over 8 years of clinical research a ...

Trial Met the Primary Endpoint and Provides Evidence of GTx-104 Clinical Benefit Compared to Orally Administered NimodipineNew Drug Application ...

Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million– Following ...

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

Spinocerebellar Ataxia (SCA) is a rare, genetic, life-threatening neurodegenerative disease with no available treatment. Troriluzole demonstrated a 50-70% slowing of SCA disease progression ...

The judge, who is not named in the judgment of BYK, R (on the application of) v Secretary of State for Defence, was found to ...

The Edo State Governorship Election Petition Tribunal sitting in Abuja, on Thursday, adjourned proceedings to Monday, ...

The edition this year promises to redefine the standards of aerospace expositions and elevate India’s global presence in the ...

Oppenheimer's Annual Healthcare Life Sciences Conference is a premier event that brings together leading companies and investors in the healthcare and life sciences sectors. The conference features ...

Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on delivering therapeutics through effective oral delivery, announced today that it has received revised regulatory guidance for LPCN ...

However, Syed Omar, 81, confirmed he did not hear what the Saudi king said to Najib. In this trial, Najib has claimed that ...

The new American tank, currently known under the working name M1E3, will be ready by 2030. The impressive pace of work on the ...